Sol De Jesus

566 total citations
32 papers, 346 citations indexed

About

Sol De Jesus is a scholar working on Neurology, Cellular and Molecular Neuroscience and General Health Professions. According to data from OpenAlex, Sol De Jesus has authored 32 papers receiving a total of 346 indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Neurology, 9 papers in Cellular and Molecular Neuroscience and 4 papers in General Health Professions. Recurrent topics in Sol De Jesus's work include Neurological disorders and treatments (23 papers), Parkinson's Disease Mechanisms and Treatments (19 papers) and Transcranial Magnetic Stimulation Studies (4 papers). Sol De Jesus is often cited by papers focused on Neurological disorders and treatments (23 papers), Parkinson's Disease Mechanisms and Treatments (19 papers) and Transcranial Magnetic Stimulation Studies (4 papers). Sol De Jesus collaborates with scholars based in United States, Mexico and Brazil. Sol De Jesus's co-authors include Michael S. Okun, Daniel Martínez-Ramírez, Mechelle M. Lewis, Xuemei Huang, Lan Kong, Leili Shahgholi, Leonardo Almeida, Guangwei Du, Roger Walz and Chris J. Hass and has published in prestigious journals such as PLoS ONE, Neurology and The American Journal of Gastroenterology.

In The Last Decade

Sol De Jesus

29 papers receiving 338 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sol De Jesus United States 12 253 102 62 40 39 32 346
Téodor Danaila France 11 238 0.9× 66 0.6× 58 0.9× 45 1.1× 62 1.6× 27 342
Alfonso Rubino Italy 10 252 1.0× 76 0.7× 47 0.8× 46 1.1× 44 1.1× 22 349
Kelly Bertram Australia 11 292 1.2× 112 1.1× 77 1.2× 31 0.8× 48 1.2× 22 367
Maria Bloise Italy 9 373 1.5× 108 1.1× 47 0.8× 36 0.9× 24 0.6× 12 410
Pravin Khemani United States 10 205 0.8× 84 0.8× 46 0.7× 63 1.6× 21 0.5× 27 342
Nelson Hwynn United States 13 366 1.4× 152 1.5× 25 0.4× 35 0.9× 48 1.2× 20 432
Nico Golfrè Andreasi Italy 9 259 1.0× 39 0.4× 48 0.8× 24 0.6× 70 1.8× 19 345
Ilse Heberlein Germany 11 221 0.9× 63 0.6× 73 1.2× 59 1.5× 23 0.6× 13 335
Е А Катунина Russia 9 239 0.9× 90 0.9× 35 0.6× 33 0.8× 42 1.1× 49 322
Alberto Cucca United States 11 180 0.7× 70 0.7× 58 0.9× 39 1.0× 88 2.3× 23 343

Countries citing papers authored by Sol De Jesus

Since Specialization
Citations

This map shows the geographic impact of Sol De Jesus's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sol De Jesus with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sol De Jesus more than expected).

Fields of papers citing papers by Sol De Jesus

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sol De Jesus. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sol De Jesus. The network helps show where Sol De Jesus may publish in the future.

Co-authorship network of co-authors of Sol De Jesus

This figure shows the co-authorship network connecting the top 25 collaborators of Sol De Jesus. A scholar is included among the top collaborators of Sol De Jesus based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sol De Jesus. Sol De Jesus is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Lewis, Mechelle M., Leslie C. Jellen, Guangwei Du, et al.. (2024). Neuropathological findings and in vivo imaging correlates of the red nucleus compared to those of the substantia nigra pars compacta in parkinsonisms. Parkinsonism & Related Disorders. 125. 107043–107043. 2 indexed citations
3.
Lewis, Mechelle M., Richard B. Mailman, Guangwei Du, et al.. (2024). Clinical progression of Parkinson's disease in the early 21st century: Insights from the accelerating medicine partnership (AMP-PD) data. Parkinsonism & Related Disorders. 130. 107186–107186. 3 indexed citations
4.
Jesus, Sol De, Mechelle M. Lewis, Douglas Leslie, et al.. (2024). Prevalence of Late‐Stage Parkinson's Disease in the US Healthcare System: Insights from TriNetX. Movement Disorders. 39(9). 1592–1601. 2 indexed citations
5.
Brown, Gregory M., et al.. (2024). Advance Care Planning Billing Codes Associated With Decreased Healthcare Utilization in Neurological Disease. Journal of Healthcare Management. 70(1). 58–73.
6.
Lewis, Mechelle M., Lauren J. Van Scoy, Sol De Jesus, et al.. (2023). Dopamine D1 Agonists: First Potential Treatment for Late-Stage Parkinson’s Disease. Biomolecules. 13(5). 829–829. 10 indexed citations
7.
McInerney, James, et al.. (2023). Cerebrotendinous xanthomatosis tremor successfully controlled post-ventral intermediate nucleus-deep brain stimulation: a case report. Frontiers in Neurology. 14. 1243379–1243379. 1 indexed citations
8.
Brown, Gregory L., Jonathan G. Hakun, Mechelle M. Lewis, et al.. (2022). Frontostriatal and limbic contributions to cognitive decline in Parkinson's disease. Journal of Neuroimaging. 33(1). 121–133. 13 indexed citations
9.
Jesus, Sol De, et al.. (2021). An Atypical Case of Respiratory Syncytial Virus (RSV) Associated Encephalitis in an Immunocompetent Patient (2788). Neurology. 96(15_supplement). 1 indexed citations
10.
Siddiqui, Mustafa, Sol De Jesus, Harini Sarva, et al.. (2021). North American Survey on the Effects of the COVID-19 Pandemic Shutdown on DBS Care (2270). Neurology. 96(15_supplement). 2 indexed citations
11.
Roper, Jaimie A., et al.. (2019). Spatiotemporal gait parameters and tremor distribution in essential tremor. Gait & Posture. 71. 32–37. 7 indexed citations
12.
Jesus, Sol De, Michael S. Okun, Kelly D. Foote, et al.. (2019). Square Biphasic Pulse Deep Brain Stimulation for Parkinson’s Disease: The BiP-PD Study. Frontiers in Human Neuroscience. 13. 368–368. 12 indexed citations
13.
Falaki, Ali, Hang Jin Jo, Mechelle M. Lewis, et al.. (2018). Systemic effects of deep brain stimulation on synergic control in Parkinson’s disease. Clinical Neurophysiology. 129(6). 1320–1332. 26 indexed citations
14.
Almeida, Leonardo, Daniel Martínez-Ramírez, Bilal Ahmed, et al.. (2017). A pilot trial of square biphasic pulse deep brain stimulation for dystonia: The BIP dystonia study. Movement Disorders. 32(4). 615–618. 15 indexed citations
15.
Jesus, Sol De, Leonardo Almeida, Leili Shahgholi, et al.. (2017). Square biphasic pulse deep brain stimulation for essential tremor: The BiP tremor study. Parkinsonism & Related Disorders. 46. 41–46. 20 indexed citations
16.
Shahgholi, Leili, Sol De Jesus, Samuel S. Wu, et al.. (2017). Hospitalization and rehospitalization in Parkinson disease patients: Data from the National Parkinson Foundation Centers of Excellence. PLoS ONE. 12(7). e0180425–e0180425. 40 indexed citations
17.
Almeida, Leonardo, Bilal Ahmed, Roger Walz, et al.. (2016). Depressive Symptoms are Frequent in Atypical Parkinsonian Disorders. Movement Disorders Clinical Practice. 4(2). 191–197. 25 indexed citations
18.
Shahgholi, Leili, Sol De Jesus, Samuel Wu, et al.. (2015). The Profile of the Hospitalized and Re-Hospitalized Parkinson Disease Patient: 5 Year Data from the National Parkinson Foundation (S48.006). Neurology. 84(14_supplement). 2 indexed citations
19.
Jesus, Sol De, et al.. (2015). Novel targets and stimulation paradigms for deep brain stimulation. Expert Review of Neurotherapeutics. 15(9). 1067–1080. 7 indexed citations
20.
Jesus, Sol De, et al.. (2015). Surprising Prevalence of Unrecognized Vitamin D3 Deficiency in Fall and Winter Months in Neuromuscular Clinics in Central Pennsylvania. Journal of Clinical Neuromuscular Disease. 16(4). 199–201. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026